|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
9
|
|
pubmed:dateCreated |
2006-8-7
|
|
pubmed:abstractText |
Five double-blind, randomized, saline-controlled trials (RCTs) were included in the United States marketing application for an intra-articular hyaluronan (IA-HA) product for the treatment of osteoarthritis (OA) of the knee. We report an integrated analysis of the primary Case Report Form (CRF) data from these trials.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
1063-4584
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
14
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
859-66
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:16626978-Aged,
pubmed-meshheading:16626978-Double-Blind Method,
pubmed-meshheading:16626978-Drug and Narcotic Control,
pubmed-meshheading:16626978-Female,
pubmed-meshheading:16626978-Humans,
pubmed-meshheading:16626978-Hyaluronic Acid,
pubmed-meshheading:16626978-Injections, Intra-Articular,
pubmed-meshheading:16626978-Male,
pubmed-meshheading:16626978-Middle Aged,
pubmed-meshheading:16626978-Osteoarthritis, Knee,
pubmed-meshheading:16626978-Pain,
pubmed-meshheading:16626978-Randomized Controlled Trials as Topic,
pubmed-meshheading:16626978-Treatment Outcome
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
An integrated analysis of five double-blind, randomized controlled trials evaluating the safety and efficacy of a hyaluronan product for intra-articular injection in osteoarthritis of the knee.
|
|
pubmed:affiliation |
Division of Immunology and Rheumatology, Stanford University, Palo Alto, CA, USA.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Meta-Analysis
|
